Simon Renders
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study.
Journal: Leukemia
Published: December 03, 2025
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML.
Journal: Cell stem cell
Published: October 09, 2025
Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.
Journal: Cancer cell
Published: July 23, 2025
A FABulous Couple: Adding PHENotype to GENotype Improves HMA/VEN Response Prediction in AML.
Journal: Blood cancer discovery
Published: July 17, 2025
Differentiation, ageing and leukaemia alter the metabolic profile of human bone marrow haematopoietic stem and progenitor cells.
Journal: Nature cell biology
Published: March 06, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML.
Journal: Blood advances
Published: March 05, 2024
An arms-race against resistance: leukemic stem cells and lineage plasticity.
Journal: Molecular oncology
Published: December 16, 2023
Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype.
Journal: Nature genetics
Published: June 22, 2023
Characterization of single neurons reprogrammed by pancreatic cancer.
Journal: Nature
Published: May 11, 2023
GPRC5C drives branched-chain amino acid metabolism in leukemogenesis.
Journal: Blood advances
Published: April 13, 2023
Last Updated: 09/26/2026